Max Healthcare Institute Future Growth
Future criteria checks 3/6
Max Healthcare Institute is forecast to grow earnings and revenue by 18.9% and 19% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 16.1% in 3 years.
Key information
18.9%
Earnings growth rate
18.7%
EPS growth rate
| Healthcare earnings growth | 27.4% |
| Revenue growth rate | 19.0% |
| Future return on equity | 16.1% |
| Analyst coverage | Good |
| Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Is Max Healthcare Institute (NSE:MAXHEALTH) Using Too Much Debt?
Jul 24Max Healthcare Institute Limited (NSE:MAXHEALTH) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Jun 01Have Insiders Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares This Year?
Feb 21What Percentage Of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares Do Insiders Own?
Jan 16
We Think Max Healthcare Institute (NSE:MAXHEALTH) Is Taking Some Risk With Its Debt
Dec 20Who Has Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Nov 15What Type Of Shareholders Own The Most Number of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Oct 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 115,497 | 22,128 | 12,410 | N/A | 2 |
| 3/31/2026 | 104,333 | 20,063 | 14,248 | N/A | 13 |
| 3/31/2025 | 83,484 | 15,874 | 6,625 | N/A | 14 |
| 3/31/2024 | 68,550 | 13,200 | 2,443 | N/A | 15 |
| 12/31/2023 | 51,976 | 10,570 | N/A | N/A | N/A |
| 9/30/2023 | 50,044 | 9,901 | 7,141 | 11,564 | N/A |
| 6/30/2023 | 47,807 | 11,708 | N/A | N/A | N/A |
| 3/31/2023 | 45,626 | 11,035 | 8,736 | 12,092 | N/A |
| 12/31/2022 | 42,799 | 9,763 | N/A | N/A | N/A |
| 9/30/2022 | 41,143 | 9,437 | 3,873 | 9,507 | N/A |
| 6/30/2022 | 39,976 | 6,310 | N/A | N/A | N/A |
| 3/31/2022 | 39,366 | 6,051 | 1,872 | 7,405 | N/A |
| 12/31/2021 | 37,978 | 5,510 | N/A | N/A | N/A |
| 9/30/2021 | 36,193 | 4,516 | 1,486 | 3,086 | N/A |
| 6/30/2021 | 32,486 | 3,236 | N/A | N/A | N/A |
| 3/31/2021 | 25,080 | -1,375 | -6 | 1,179 | N/A |
| 12/31/2020 | 27,772 | -1,177 | N/A | N/A | N/A |
| 9/30/2020 | 22,487 | -2,134 | 3,024 | 3,911 | N/A |
| 6/30/2020 | 14,849 | -2,681 | N/A | N/A | N/A |
| 3/31/2020 | 10,590 | 590 | -130 | 771 | N/A |
| 12/31/2019 | 10,081 | 268 | N/A | N/A | N/A |
| 9/30/2019 | 18,609 | 720 | N/A | N/A | N/A |
| 6/30/2019 | 17,719 | 360 | N/A | N/A | N/A |
| 3/31/2019 | 16,939 | -30 | -268 | 890 | N/A |
| 6/30/2018 | 17,053 | -704 | N/A | N/A | N/A |
| 3/31/2018 | 17,303 | -302 | 167 | 822 | N/A |
| 3/31/2017 | 16,085 | -14 | N/A | 1,561 | N/A |
| 3/31/2016 | 14,343 | -180 | N/A | 7,225 | N/A |
| 3/31/2015 | 7,896 | -381 | N/A | 387 | N/A |
| 3/31/2014 | 9,445 | -646 | N/A | 732 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MAXHEALTH's forecast earnings growth (18.9% per year) is above the savings rate (6.7%).
Earnings vs Market: MAXHEALTH's earnings (18.9% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: MAXHEALTH's earnings are forecast to grow, but not significantly.
Revenue vs Market: MAXHEALTH's revenue (19% per year) is forecast to grow faster than the Indian market (10.3% per year).
High Growth Revenue: MAXHEALTH's revenue (19% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MAXHEALTH's Return on Equity is forecast to be low in 3 years time (16.1%).